The company, however, continues to work on a phase 1/2 study of its H5 mRNA flu vaccine for pandemic preparedness.
Vaccine effectiveness against severe illness was 43% among children with underlying conditions and 53% among those without.
Older adults have higher risks of certain diseases because they have more underlying illnesses and because immune systems weaken with age.
Despite a partial vaccine mismatch this season, say researchers, vaccine effectiveness was statistically significant across all age-groups.
The analysis looked at more than 332,000 adults in Denmark aged 65 and older.
But vaccine uptake was suboptimal, particularly for the flu vaccine.
The category sounds reasonable, even collaborative. It is neither. And it will put children’s health and lives at risk.
Both the CDC and WHO say preliminary UK data show the current flu vaccine offers strong protection against subclade K.
Different bacteria, viruses, and fungi have been suggested as possible causative pathogens for Parkinson’s.
The comments centered on a memo from FDA Center for Biologics Evaluation and Research Director Vinay Prasad.
